Category: Analysis - Page 12 - Psychedelic Alpha

Read more about the article An Abridged History of Psychedelic Use and Criminalisation

An Abridged History of Psychedelic Use and Criminalisation

Post published:June 27, 2023
Post category:Analysis

Read more about the article Field Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?

Field Trip’s Downfall: Too Early, Too Aggressive, Too Extravagant?

Post published:March 28, 2023
Post category:Analysis

Read more about the article Reunion Sues Mindset, Claims it Copied RE104

Reunion Sues Mindset, Claims it Copied RE104

Post published:March 15, 2023
Post category:Analysis

Read more about the article Inside Synthesis Institute’s Implosion

Inside Synthesis Institute’s Implosion

Post published:March 7, 2023
Post category:Analysis

Read more about the article <strong>Australia Recognises MDMA and Psilocybin as Medicines</strong>

Australia Recognises MDMA and Psilocybin as Medicines

Post published:February 3, 2023
Post category:Analysis

Read more about the article atai’s PCN-101 Candidate Fails to Meet Primary Endpoint in Heavily-Anticipated Phase 2a Trial

atai’s PCN-101 Candidate Fails to Meet Primary Endpoint in Heavily-Anticipated Phase 2a Trial

Post published:January 6, 2023
Post category:Analysis

Read more about the article Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai’s PCN-101 Phase 2a Readout

Racing Beyond Racemic: A Look at Ketamine Drug Development Ahead of atai’s PCN-101 Phase 2a Readout

Post published:November 17, 2022
Post category:Analysis

Read more about the article Analysis: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Analysis: COMPASS Pathways Phase 2b Psilocybin Trial Published in NEJM

Post published:November 2, 2022
Post category:Analysis

Read more about the article Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

Inside the Challenge to DEA’s Proposed Scheduling of 5 Psychedelic Tryptamines

Post published:July 29, 2022
Post category:Analysis News

Read more about the article Looking Ahead to a Psychedelic 2022

Looking Ahead to a Psychedelic 2022

Post published:February 3, 2022
Post category:Analysis

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.